Results 1 to 10 of about 4,993 (219)

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial. [PDF]

BMJ Open
Marques T, Forsyth C, Barreira F, Lombas C, Blum de Oliveira B, Laserna M, Molina I, Bangher MDC, Javier Fernández R, Lloveras S, Fernández ML, Scapellato P, Patterson P, Garcia W, Ortiz L, Schijman A, Moreira OC, García L, Viele K, Longhi S, Vaillant M, Tipple C, Fraisse L, Silvestre-Sousa A, Sosa-Estani S, Pinazo MJ.   +25 more
europepmc   +1 more source

[Risk of transfusion and transplantation transmission of <i>Trypanosoma cruzi</i> infection in endemic countries in the AmericasRisco de infecção por <i>Trypanosoma cruzi</i> por transfusão e transplante em países endêmicos da Região das Américas]. [PDF]

Rev Panam Salud Publica
Beltrán M, Remesar M, Menjivar A, Barco G.   +3 more
europepmc   +1 more source

Parásitos intestinales. Enfermedad de Chagas

Biomédica, 2011
openaire   +3 more sources

Triatomines outside the Americas: a comprehensive dataset for the global surveillance of Chagas disease vectors. [PDF]

GigaByte
Ceccarelli S, Vicente ME, Liu Q, Zhou XN, Wu D, Balsalobre A, Bruno EA, Barboza SE, Valente R, Marti GA.   +9 more
europepmc   +1 more source

Imunopatogénesis de la Enfermedad de Chagas

, 2002
RESUMEN Los mecanismos que llevan a un 30% de los pacientes con infección por Trypanosoma cruzi a desarrollar la enfermedad de Chagas produciendo un síndrome cardíaco o digestivo, han sido objeto de un amplio debate. Por más de 50 años se atribuyó como causa primaria mecanismos de tipo autoinmune.
openaire   +1 more source

Spatial and temporal distribution of neglected tropical diseases: overlap analysis, Piauí, 2013-2022. [PDF]

Epidemiol Serv Saude
Araújo LBS, Sousa RA, Aguiar BGA, Mendonça VJ, Araújo OD, Tajra FS.   +5 more
europepmc   +1 more source

A four-step process for building sustainable access to diagnosis and treatment of Chagas disease. [PDF]

Rev Panam Salud Publica, 2019
Batista C, Forsyth CJ, Herazo R, Certo MP, Marchiol A.   +4 more
europepmc   +1 more source

[Environmental medicine and AI, migration, and emerging and reemerging diseases in Mexico]. [PDF]

Rev Med Inst Mex Seguro Soc
Rivera-Silva G, Moreno-Treviño MG, Garza-Martínez R.   +2 more
europepmc   +1 more source

Enfermedad de Chagas (Tripanosomiasis Americana)

Evidencia, actualizacion en la práctica ambulatoria, 2004
openaire   +3 more sources

Towards effective coverage of Chagas disease: a community-based approach in migrant populations. [PDF]

Int J Equity Health
Gómez I Prat J, Fernández-Torres P, Guiu IC, Circuns AG, Alguacil HM, Choque E, Gold M, Dehousse A, Albajar-Vinas P, Zarzuela F, Igual ES, Romero IM, Mendioroz J, Essadek HO.   +13 more
europepmc   +1 more source